SCHEMBL24190271

SCHEMBL24190271

CC(=O)OC(C(=O)NCCOCC(C)C)[C@H](C[C@@H]1CCNC1=O)NC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 1/20 0.35
CTSL P07711 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24190300 0.90 CAPN1 (0.38) CAPN1CTSL
SCHEMBL29015641 0.85 CTSL (0.37) CTSL
SCHEMBL29015640 0.85 CTSL (0.37) CTSL
SCHEMBL24014373 0.84 CTSL (0.37) CTSL
SCHEMBL30170256 0.82 CTSL (0.38) CTSL
SCHEMBL26466628 0.82 CTSL (0.38) CTSL
SCHEMBL31475423 0.81 HDAC4 (0.41) CTSL
SCHEMBL25284440 0.80 CTSL (0.50) CAPN1CTSL
SCHEMBL25243264 0.80 CTSL (0.50) CAPN1CTSL
SCHEMBL25284441 0.80 CTSL (0.50) CAPN1CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220009903-A1 ANTI-VIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220009903-A1 ANTI-VIRAL COMPOUNDS EIF2AK2, ZC3HAV1, HAVCR2 CAPN1 3014/4885CTSL 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.